Sort by
Refine Your Search
-
Country
-
Employer
- Karolinska Institutet
- SciLifeLab
- Radboud University
- Aalborg University
- AcademicTransfer
- Centre for Genomic Regulation
- KU Leuven
- University of Bergen
- ;
- ; Newcastle University
- ; Swansea University
- ; University of Plymouth
- Aix-Marseille University - CNRS
- Biomedical Campus Krč
- Cranfield University
- Delft University of Technology
- Delft University of Technology (TU Delft)
- ETH Zurich
- Erasmus MC (University Medical Center Rotterdam)
- FARM-ID - Associação da Faculdade de Farmácia para a Investigação e Desenvolvimento
- Ghent University
- Hasselt University
- Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt
- Institute of Bioorganic Chemistry Polish Academy of Sciences
- Instituto de Investigação e Inovação em Saúde da Universidade do Porto (i3S)
- Karolinska Institutet, doctoral positions
- Medical University of Lodz
- Radboud University Medical Center (Radboudumc)
- Radboudumc
- Swansea University
- Synklino
- The Netherlands Cancer Institute
- University of Salzburg
- University of Twente
- University of Zimbabwe
- Uppsala University
- Utrecht University
- Vrije Universiteit Amsterdam (VU)
- 28 more »
- « less
-
Field
-
need for innovative technologies that can address current challenges facing cell and gene therapy biomanufacture. Major advances are needed to enrich process integrated analytical tools, enabling
-
the mechanisms involved in tumour evolution, to predict the effect of a variety of therapies and to optimize the therapeutic protocols. Integration of metabolism is relatively recent and up to now, there is no
-
is to assess and optimize innovative medical therapies that can elicit favorable effects in the patients and promote heart recovery. For this purpose, this PhD is focused on developing an innovative
-
of their microbiota. This characterisation will help to predict the success of the biological therapy and thus has potential to tailor the appropriate therapy. Specific goals: 1) To identify consortia of bacteria
-
, Belgium) is looking for a highly motivated PhD student to unravel the cellular and molecular mechanisms underlying food reactivity and response to dietary and anti-inflammatory therapy in patients with
-
Physics » Applied physics Physics » Other Researcher Profile First Stage Researcher (R1) Country Belgium Application Deadline 15 Jun 2024 - 21:59 (UTC) Type of Contract Temporary Job Status Full-time Hours
-
on the progression of hormone-dependent and hormone-independent cancers. We cooperates with Technical University of Lodz to design and use novel polymer-based radioisotope nanocarriers in cancer therapies. We
-
identify better who will benefit most from therapy and when. As a PhD candidate, you will chart the current management approaches in Belgium and Europe building a (inter)national NTM registry whilst
-
benefit from standard first-line therapy but promising individualized therapies such as CAR-T cell therapy are under development. To better asses which patients are eligible for new innovative therapies
-
PhD position: Definition of transcriptional units of Inherited Retinal Disease genes at TIGEM, Italy
biology, genome editing, animal models of disease, and the development of novel therapeutic approaches such as gene therapy. In recent years, human geneticists, have identified a large proportion of the